Because semaglutide has a long (~7-day) half-life1, a missed weekly dose does not cause levels to fall off a cliff — the pharmacology cushions it. What to actually *do* about a missed dose is a clinical question for the label and a clinician; this page explains only the underlying kinetics.

In plain terms: the compound fades slowly, so being a few days late is a gentle slope, not a sudden drop.

Why the half-life cushions a miss

With a ~7-day half-life, roughly half of the last dose is still present a week later1. If a dose is missed and the gap stretches from 7 to, say, 10–11 days, levels have declined further along the decay curve but a substantial fraction remains:

Days since last doseApprox. remaining of that dose
7 (normal interval)~50%
10~37%
14~25%

These follow directly from the half-life math2. At steady-state there is additional accumulated compound on board too, further softening the dip.

The takeaway

A long half-life is what makes weekly dosing forgiving: the level curve slopes gently rather than spiking and crashing. That is a description of pharmacokinetics — not guidance on timing, redosing, or catching up, which belong to the product label and a clinician.

A tracker that plots the actual decay from your logged doses shows the dip a missed dose creates. Zyra Labs does this from your own log — as information, not instruction, and never as medical advice.